Aspire Biosciences

Aspire Biosciences is a Cambridge-based company accelerating treatment development for rare and unaddressed diseases through its Systematic Serendipity methodology.

The company facilitates structured partnerships between rare disease patient organisations and pharmaceutical and biotechnology companies through cohort-based partnering programmes and algorithmic asset matching.

Cohorts address specific therapeutic areas including rare neurology, haematology and metabolic diseases, connecting patient group teams with company assets through guided in-person events and a searchable database.